We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

49 hedge funds and large institutions have $43.4M invested in abrdn Life Sciences Investors in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 18

1.02% less ownership

Funds ownership: 13.53% → 12.51% (-1%)

6% less funds holding

Funds holding: 52 → 49 (-3)

30% less capital invested

Capital invested by funds: $61.8M → $43.4M (-$18.3M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
17
Reduced
18
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DA
Doliver Advisors
Texas
+$971K
2
Citigroup
Citigroup
New York
+$817K
3
Morgan Stanley
Morgan Stanley
New York
+$527K
4
NIM
Needham Investment Management
New York
+$261K
5
UCFA
United Capital Financial Advisors
Texas
+$197K

Top Sellers

Rank Fund Capital Flow
1
AAM
Advisors Asset Management
Colorado
-$2.14M
2
CS
Credit Suisse
Switzerland
-$1.23M
3
UR
USCA RIA
Texas
-$848K
4
Wells Fargo
Wells Fargo
California
-$778K
5
UBS Group
UBS Group
Switzerland
-$651K
Name Holding Trade Value Shares
Change 		Change in
Stake
UCFA
26
United Capital Financial Advisors
Texas
$195K +$197K +10,863 New
Creative Planning
27
Creative Planning
Kansas
$189K +$100K +5,508 +109%
MIC
28
Meridian Investment Counsel
California
$183K -$36.3K -2,000 -16%
IA
29
IFP Advisors
Florida
$135K -$79.1K -4,355 -35%
VNA
30
Valley National Advisers
Pennsylvania
$58K – – –
PNC Financial Services Group
31
PNC Financial Services Group
Pennsylvania
$56K -$26K -1,431 -32%
US Bancorp
32
US Bancorp
Minnesota
$31K – – –
NSIM
33
North Star Investment Management
Illinois
$21K +$1.16K +64 +6%
KLI
34
Kelman-Lazarov Inc
Tennessee
$21K +$20.9K +1,150 New
NFG
35
Next Financial Group
Texas
$19K – – –
Northwestern Mutual Wealth Management
36
Northwestern Mutual Wealth Management
Wisconsin
$18K +$18.3K +1,010 +25,250%
SIA
37
SeaBridge Investment Advisors
New Jersey
$17K – – –
MSFP
38
Mark Sheptoff Financial Planning
Connecticut
$12K +$3.69K +203 +44%
BC
39
Barnett & Company
Tennessee
$9K – – –
AIM
40
Arcadia Investment Management
Michigan
$7K – – –
Deutsche Bank
41
Deutsche Bank
Germany
$5K – – –
ASN
42
Advisory Services Network
Georgia
$1K -$29K -1,600 -96%
TFA
43
Transamerica Financial Advisors
Florida
$1K – – –
TJHA
44
Thomas J. Herzfeld Advisors
Florida
$1K +$18 +1 +2%
CS
45
Credit Suisse
Switzerland
– -$1.23M -52,108 Closed
UR
46
USCA RIA
Texas
– -$848K -35,879 Closed
WS
47
Wedbush Securities
California
– -$285K -12,059 Closed
GT
48
Glenmede Trust
Pennsylvania
– -$196K -10,800 -100%
RJA
49
Raymond James & Associates
Florida
– -$247K -10,451 Closed
WAM
50
Weiss Asset Management
Massachusetts
– -$237K -10,036 Closed
1
2
3

HQL Hedge Fund Activity: Q1 2016 in Review

49 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2016, worth a combined $43.4M — down 30% from $61.8M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of HQL and 3 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 17 added.

The largest buyer was Doliver Advisors, adding an estimated $971K. The largest seller was Advisors Asset Management, cutting an estimated $2.14M.

  • 49 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2016, down from 52 in Q4 2015.
  • Funds reported $43.4M of abrdn Life Sciences Investors stock for Q1 2016, down 30% quarter-over-quarter.
  • 3 funds opened new abrdn Life Sciences Investors positions in Q1 2016 and 6 closed out, a net change of -3 holders.
  • The largest abrdn Life Sciences Investors buyer in Q1 2016 was Doliver Advisors, an estimated $971K added.
  • The largest abrdn Life Sciences Investors seller in Q1 2016 was Advisors Asset Management, an estimated $2.14M sold.

Based on aggregated 13F filings for Q1 2016.